Loading
Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted.
Brian Huntly is President Elect of the European Hematology Association and Professor of Leukaemia Stem Cell Biology at the University of Cambridge. His group investigates the transcriptional and epigenetic mechanisms that initiate and maintain acute myeloid leukaemia. He combines clinical haematology practice with laboratory research on novel leukaemia therapies.
| Title | Journal | Year |
|---|---|---|
| Leukaemia stem cells and the evolution of cancer-stem-cell research | Nature Reviews Cancer | 2005 |
| Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance | Blood | 2016 |
| Targeting Epigenetic Readers in Cancer | New England Journal of Medicine | 2012 |
Shares European Hematology Association, Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
Shares European Hematology Association, Acute myeloid leukaemia.
Shares Acute myeloid leukaemia and the tags clinician-scientist, haematology, leukaemia.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.